←Destined RivalsDestined Rivals🃏All Electabuzz cards
Ask about Electabuzz
Electabuzz #68 Pokémon card from Destined Rivals

Electabuzz 68/182

Destined Rivals

Find this card on eBay

Affiliate link · we may earn commission

Electabuzz #68 from Destined Rivals currently trades at $0.15 raw, with PSA 10 copies reaching $30.48 — a 203.2x grade premium.
Current Prices (USD)
Ungraded
$0.15
PSA 7
$19.00
PSA 8
$19.00
PSA 9
$19.00
PSA 10
$30.48
ACE 10
—
BGS 10 Black
$200.00
CGC 10 Pristine
$32.00
Compare on eBay

Affiliate link · we may earn commission

Quick price facts

Electabuzz 68/182 from Destined Rivals has a current raw market value of $0.15.

Current raw value
$0.15
PSA 9 value
$19.00
PSA 10 value
$30.48
View all cards from Destined Rivals →
Collector Intel
203.2x
Raw → PSA 10
High-risk grade
126.7x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

⚠️ High-variance grade. PSA 10 is 203x the raw price. The expected value accounts for the realistic probability.
$0
Buy Raw
~$25
Grading Fee
PSA Standard
$30
PSA 10 Value
+$5
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$19126.7x raw
PSA 10$30203.2x raw

Frequently asked questions

How much is Electabuzz #68 from Destined Rivals worth?+
Electabuzz #68 from Destined Rivals is currently worth Raw: $0.15, PSA 9: $19.00, PSA 10: $30.48 based on recent sold listings. Prices update daily from real eBay sales.
Is Electabuzz #68 worth grading?+
The PSA 10 price of $30.48 is 203.2× the raw price of $0.15. After a ~$25 grading fee, a PSA 10 result would net approximately $30.33 — assuming the card grades a 10.
Where do PokePrices Electabuzz #68 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.